Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors may be associated with pharmacovigilance signals for ...

The resistance of cancer cells to radiation therapy is a significant clinical problem in treating cancer. Many solid tumors are only partially responsive to radiation therapy, and increasing radiation ...

Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...

The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...

Please provide your email address to receive an email when new articles are posted on . GENEVA — Exposure to proton pump inhibitors appeared associated with increased risk for certain cancers, ...

Frequently prescribed medications for gastric acidity, such as proton pump inhibitors, are the subject of recurring discussions about their long-term safety. Previous studies had indeed cast ...

A reduction in urinary citrate levels may be the mechanism underlying the higher incidence of kidney stones in patients taking PPIs, according to investigators. Individuals who use proton pump ...

Regular use of proton pump inhibitors (PPIs) was significantly associated with a greater risk for inflammatory bowel disease (IBD) and its subtypes, a pooled analysis of three observational studies ...

A new study found a link between certain types of acid reflux medications and dementia. Patients who took proton pump inhibitors consistently for more than 4.4 years had a greater risk of dementia ...

For acute intracerebral hemorrhage, intensive blood pressure lowering was consistently linked to less neurological deterioration and better physical function without evidence of hematoma growth on CT, ...